LLGL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.455780E-01
Normal-vs-Stage2
5.393800E-01
Normal-vs-Stage3
1.454450E-01
Normal-vs-Stage4
3.386000E-01
Stage1-vs-Stage2
7.760800E-01
Stage1-vs-Stage3
5.341400E-01
Stage1-vs-Stage4
7.090200E-01
Stage2-vs-Stage3
5.010400E-01
Stage2-vs-Stage4
9.968800E-01
Stage3-vs-Stage4
4.397400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.592200E-01
Normal-vs-AfricanAmerican
1.460160E-01
Normal-vs-Asian
1.896430E-01
Caucasian-vs-AfricanAmerican
7.469600E-01
Caucasian-vs-Asian
5.928400E-01
AfricanAmerican-vs-Asian
6.949800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.751160E-01
Normal-vs-Female
7.801400E-01
Male-vs-Female
8.053800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.348600E-01
Normal-vs-Age(41-60Yrs)
6.671800E-01
Normal-vs-Age(61-80Yrs)
4.841800E-01
Normal-vs-Age(81-100Yrs)
4.270200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.952200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.442000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.733600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.808100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.121200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.234800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.018050E-01
Normal-vs-Daily Drinker
1.063610E-01
Normal-vs-Weekly Drinker
9.518600E-01
Normal-vs-Occasional Drinker
6.627000E-01
Normal-vs-Social Drinker
3.434200E-01
Non Drinker-vs-Daily Drinker
9.401000E-01
Non Drinker-vs-Weekly Drinker
1.255590E-01
Non Drinker-vs-Occasional Drinker
8.641900E-02
Non Drinker-vs-Social Drinker
1.516170E-01
Daily Drinker-vs-Weekly Drinker
1.386610E-01
Daily Drinker-vs-Occasional Drinker
1.240620E-01
Daily Drinker-vs-Social Drinker
1.857030E-01
Weekly Drinker-vs-Occasional Drinker
6.234600E-01
Weekly Drinker-vs-Social Drinker
4.363600E-01
Occasional Drinker-vs-Social Drinker
6.976000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.248800E-01
Normal-vs-Grade 2
7.439000E-01
Normal-vs-Grade 3
7.378400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.298200E-01
Grade 1-vs-Grade 3
7.094400E-01
Grade 1-vs-Grade 4
7.248800E-01
Grade 2-vs-Grade 3
8.464200E-01
Grade 2-vs-Grade 4
7.439000E-01
Grade 3-vs-Grade 4
7.378400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.468200E-01
Normal-vs-NonDiabetic
6.641400E-01
Diabetic-vs-NonDiabetic
2.385000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.559400E-01
Normal-vs-NoPancreatitis
3.034600E-01
Pancreatitis-vs-NoPancreatitis
3.505400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.374770E-01
Normal-vs-N1
5.865200E-01
N0-vs-N1
2.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.246030E-01
Normal-vs-TP53-NonMutant
2.116600E-01
TP53-Mutant-vs-TP53-NonMutant
5.555600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
